Author Correction: KRAS inhibitors, approved
Nat Cancer
.
2022 Apr;3(4):518.
doi: 10.1038/s43018-022-00372-3.
Authors
Rafael Rosell
1
2
3
,
Andrés Aguilar
4
,
Carlos Pedraz
5
,
Imane Chaib
5
Affiliations
1
Catalan Institute of Oncology, Badalona, Spain. rrosell@iconcologia.net.
2
Oncology Institute Dr Rosell, IOR, Barcelona, Spain. rrosell@iconcologia.net.
3
Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain. rrosell@iconcologia.net.
4
Oncology Institute Dr Rosell, IOR, Barcelona, Spain.
5
Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
PMID:
35379985
DOI:
10.1038/s43018-022-00372-3
No abstract available
Publication types
Published Erratum